Dow Up 0.11% Nasdaq Up 0.50%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
6.22 Up 0.21(3.49%) Aug 29, 4:00PM EDT
|After Hours : 6.21 Down 0.01 (0.16%) Aug 29, 4:49PM EDT
Prev Close:6.01
Open:6.03
Bid:6.08 x 1000
Ask:6.25 x 500
1y Target Est:8.73
Beta:1.05
Next Earnings Date:N/A
Day's Range:5.97 - 6.22
52wk Range:2.62 - 6.24
Volume:1,600,737
Avg Vol (3m):2,027,050
Market Cap:1.07B
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVNR

Comparison

Symbol% ChgMkt Cap
AVNRUp 3.49%1.07B
BMYUp 0.22%83.97B
LLYUp 0.71%68.12B
GSKUp 0.47%117.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback